Invesco Ltd. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,104,984
-64.6%
53,928
-65.7%
0.00%
-100.0%
Q2 2023$3,121,160
+346.6%
157,079
+285.0%
0.00%
Q1 2023$698,819
-67.1%
40,795
-62.4%
0.00%
-100.0%
Q4 2022$2,120,937
+274.1%
108,377
+204.8%
0.00%
Q3 2022$567,000
+12.1%
35,558
-3.3%
0.00%
Q2 2022$506,000
-9.3%
36,783
+4.3%
0.00%
Q1 2022$558,000
+37.8%
35,255
+90.5%
0.00%
Q4 2021$405,000
-36.5%
18,506
-13.3%
0.00%
Q3 2021$638,000
-92.7%
21,355
-89.2%
0.00%
-100.0%
Q2 2021$8,761,000
-29.9%
197,817
-29.8%
0.00%
-33.3%
Q1 2021$12,502,000
-57.8%
281,774
-47.8%
0.00%
-66.7%
Q4 2020$29,617,000
+208.9%
540,068
+28.8%
0.01%
+200.0%
Q3 2020$9,588,000
+9.4%
419,425
+0.2%
0.00%0.0%
Q2 2020$8,763,000
+8.1%
418,657
-28.0%
0.00%0.0%
Q1 2020$8,109,000
-39.0%
581,304
-0.5%
0.00%
-25.0%
Q4 2019$13,301,000
+93.6%
584,398
-0.9%
0.00%
+100.0%
Q3 2019$6,872,000
-22.3%
589,8720.0%0.00%0.0%
Q2 2019$8,848,000
-14.5%
589,872
+0.0%
0.00%
-33.3%
Q1 2019$10,346,000
+18.3%
589,868
-0.1%
0.00%0.0%
Q4 2018$8,747,000
-25.5%
590,235
+23.7%
0.00%
-25.0%
Q3 2018$11,745,000
+518.8%
477,040
+393.2%
0.00%
+300.0%
Q2 2018$1,898,00096,7300.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders